πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7405314

Compounds and methods for the treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405287

Method of treating a cancer

The Board of Regents of the University of Texas System Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405286

Starsβ€”A muscle-specific actin-binding protein

The Board of Regents of the University of Texas System Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7384909

Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to ant

The Board of Regents of the University of Texas System Β· Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378386

Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371364

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368232

High-throughput assay for virus entry and drug screening

The Board of Regents of the University of Texas System Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7365096

Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

The Board of Regents of the University of Texas System Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354912

Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compo

The Board of Regents of the University of Texas System Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7348153

Method for identifying and designing immunogenic peptides

The Board of Regents of the University of Texas System Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7344829

Methods for detecting the efficacy of anticancer treatments

The Board of Regents of the University of Texas System Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7344724

UspA1 and UspA2 antigens of Moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7338758

Compositions and methods for the identification, assessment, prevention and therapy of hum

The Board of Regents of the University of Texas System Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332469

Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects ag

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332321

Viral fibers

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329642

Ξ²-2-glycoprotein is an inhibitor of angiogenesis

The Board of Regents of the University of Texas System Β· Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7319000

Compositions and methods for eliciting immune or anti-infective responses

The Board of Regents of the University of Texas System Β· Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314911

Prostate hyperplasia therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7312202

Rationally designed and chemically synthesized promoter for genetic vaccine and gene thera

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7309692

Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-n

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7309792

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306804

HIV-specific T-cell induction

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7303887

Mule: Mcl-1 ubiquitination ligase E3

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7291348

Compositions and methods for biodegradable microspheres as carriers of bioactive substance

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted